Laboratoires Thea [clinicaltrials_resource:946184c4eeb3a96f61a79225badf46d8]
clinicaltrials:NCT01089608Evaluation of the Effect and Tolerance of Preservative Free NAAGA on the Inflammatory Component and Symptoms of Dry Eye Syndrome in Allergic Conjunctivitis Patients [clinicaltrials:NCT01203540]Assessment of Patient's Satisfaction Regarding the Handiness of Two Hyaluronic Acid Eye Drops Vials [clinicaltrials:NCT01546012]Management of Eyelid Disorders by Ophthalmologists in Usual Medical Practice [clinicaltrials:NCT01552174]
collaborator [clinicaltrials_vocabulary:collaborator]
Efficacy and Safety of 2 Dosing Regimens of T1225 Eye Drops 1.5% Versus Oral Azithromycin in Treatment of Trachoma [clinicaltrials:NCT00356720]Azithromycin Level in Tears and in Conjunctiva in 36 Healthy Volunteers [clinicaltrials:NCT00356772]Ocular Pharmacokinetics After a Single Drop Instillation of T1225 0.5, 1, 1.5% in 91 Healthy Volunteers [clinicaltrials:NCT00356850]Study of the Clinical and Biological Efficacity of NAAXIA SINE® in Vernal Keratoconjunctivitis [clinicaltrials:NCT00357019]Efficacy of T1675 Versus Placebo in Patients With Bilateral Treated Moderate Dry Eye Syndrome [clinicaltrials:NCT00357201]Ocular Tolerance, Safety and Ocular Pharmacokinetics After 1 Drop of T1225 0.5, 1.0, 1.5% in 48 Healthy Volunteers [clinicaltrials:NCT00357292]Study of the Ocular Safety After Repeated Instillations of T1225 1% or 1.5% Eye Drops in Healthy Volunteers [clinicaltrials:NCT00357383]Safety and Ocular Pharmacokinetics After 1 Drop of T1225 0.5, 1 and 1.5% in 48 Healthy Volunteers [clinicaltrials:NCT00357539]Efficacy and Safety of T1225 1.5% Versus Tobramycin 0.3 % in the Treatment of Purulent Bacterial Conjunctivitis [clinicaltrials:NCT00357773]Clinical Safety Study on an Eyelid Warming Device to Evaluate the Eyelid and Cornea Temperature in Healthy Volunteers [clinicaltrials:NCT01086943]clinicaltrials:NCT01089608Evaluation of Satisfaction Regarding Patient's Management of Ocular Surface Diseases [clinicaltrials:NCT01091311]clinicaltrials:NCT01155219Clinical Efficacy and Safety of T1225 Versus Tobramycin 0.3 % Eye Drops in the Treatment of Purulent Bacterial Conjunctivitis of Children. [clinicaltrials:NCT01155999]Efficacy and Safety Assessment of T2345 in Ocular Hypertensive or Glaucomatous Patients [clinicaltrials:NCT01156012]Efficacy and Safety of GV 550 in Acute Adenovirus Keratoconjunctivitis [clinicaltrials:NCT01156025]Evaluation of Satisfaction Regarding Patient's Management of Ocular Surface Diseases [clinicaltrials:NCT01189474]Warming Efficiency of Warm Compresses Versus BLEPHASTEAM® in Eyelid Therapy [clinicaltrials:NCT01190397]Evaluation of the Effect and Tolerance of Preservative Free NAAGA on the Inflammatory Component and Symptoms of Dry Eye Syndrome in Allergic Conjunctivitis Patients [clinicaltrials:NCT01203540]Comparison of the Efficacy and Tolerability of T1210 and Olopatadine Hydrochloride 0.1% in the Treatment of Seasonal Allergic Conjunctivitis [clinicaltrials:NCT01344083]Pharmacokinetics, Efficacy and Safety Assessment of T2345 Compared With Active Comparator in Newly Diagnosed Patients With Open-angle Glaucoma or Ocular Hypertension [clinicaltrials:NCT01494753]Assessment of Patient's Satisfaction Regarding the Handiness of Two Hyaluronic Acid Eye Drops Vials [clinicaltrials:NCT01546012]Management of Eyelid Disorders by Ophthalmologists in Usual Medical Practice [clinicaltrials:NCT01552174]Comparison of the Efficacy and Safety of T2750 and Vismed® in the Treatment of Moderate to Severe Dry Eye Syndrome [clinicaltrials:NCT01568593]Efficacy and Safety Assessment of T4020 Versus Vehicule in Patients With Chronic Neurotrophic Keratitis or Corneal Ulcer [clinicaltrials:NCT01794312]Safety and Efficacy Assessment of Monoprost® in Comparison With Lumigan® 0.01 % and Lumigan® 0.03% Unit Dose [clinicaltrials:NCT02017327]Efficacy and Safety of T2762 and Vismed® in Dry Eye Syndrome [clinicaltrials:NCT02023268]clinicaltrials:NCT02101359Efficacy and Safety Assessment of T2347 Versus Xalacom® in Ocular Hypertensive or Glaucomatous Patients [clinicaltrials:NCT02278614]
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
Efficacy and Safety of 2 Dosing Regimens of T1225 Eye Drops 1.5% Versus Oral Azithromycin in Treatment of Trachoma [clinicaltrials:NCT00356720]Azithromycin Level in Tears and in Conjunctiva in 36 Healthy Volunteers [clinicaltrials:NCT00356772]Ocular Pharmacokinetics After a Single Drop Instillation of T1225 0.5, 1, 1.5% in 91 Healthy Volunteers [clinicaltrials:NCT00356850]Study of the Clinical and Biological Efficacity of NAAXIA SINE® in Vernal Keratoconjunctivitis [clinicaltrials:NCT00357019]Efficacy of T1675 Versus Placebo in Patients With Bilateral Treated Moderate Dry Eye Syndrome [clinicaltrials:NCT00357201]Ocular Tolerance, Safety and Ocular Pharmacokinetics After 1 Drop of T1225 0.5, 1.0, 1.5% in 48 Healthy Volunteers [clinicaltrials:NCT00357292]Study of the Ocular Safety After Repeated Instillations of T1225 1% or 1.5% Eye Drops in Healthy Volunteers [clinicaltrials:NCT00357383]Safety and Ocular Pharmacokinetics After 1 Drop of T1225 0.5, 1 and 1.5% in 48 Healthy Volunteers [clinicaltrials:NCT00357539]Efficacy and Safety of T1225 1.5% Versus Tobramycin 0.3 % in the Treatment of Purulent Bacterial Conjunctivitis [clinicaltrials:NCT00357773]Clinical Safety Study on an Eyelid Warming Device to Evaluate the Eyelid and Cornea Temperature in Healthy Volunteers [clinicaltrials:NCT01086943]clinicaltrials:NCT01089608Evaluation of Satisfaction Regarding Patient's Management of Ocular Surface Diseases [clinicaltrials:NCT01091311]clinicaltrials:NCT01155219Clinical Efficacy and Safety of T1225 Versus Tobramycin 0.3 % Eye Drops in the Treatment of Purulent Bacterial Conjunctivitis of Children. [clinicaltrials:NCT01155999]Efficacy and Safety Assessment of T2345 in Ocular Hypertensive or Glaucomatous Patients [clinicaltrials:NCT01156012]Efficacy and Safety of GV 550 in Acute Adenovirus Keratoconjunctivitis [clinicaltrials:NCT01156025]Evaluation of Satisfaction Regarding Patient's Management of Ocular Surface Diseases [clinicaltrials:NCT01189474]Warming Efficiency of Warm Compresses Versus BLEPHASTEAM® in Eyelid Therapy [clinicaltrials:NCT01190397]Evaluation of the Effect and Tolerance of Preservative Free NAAGA on the Inflammatory Component and Symptoms of Dry Eye Syndrome in Allergic Conjunctivitis Patients [clinicaltrials:NCT01203540]Comparison of the Efficacy and Tolerability of T1210 and Olopatadine Hydrochloride 0.1% in the Treatment of Seasonal Allergic Conjunctivitis [clinicaltrials:NCT01344083]Pharmacokinetics, Efficacy and Safety Assessment of T2345 Compared With Active Comparator in Newly Diagnosed Patients With Open-angle Glaucoma or Ocular Hypertension [clinicaltrials:NCT01494753]Assessment of Patient's Satisfaction Regarding the Handiness of Two Hyaluronic Acid Eye Drops Vials [clinicaltrials:NCT01546012]Management of Eyelid Disorders by Ophthalmologists in Usual Medical Practice [clinicaltrials:NCT01552174]Comparison of the Efficacy and Safety of T2750 and Vismed® in the Treatment of Moderate to Severe Dry Eye Syndrome [clinicaltrials:NCT01568593]Efficacy and Safety Assessment of T4020 Versus Vehicule in Patients With Chronic Neurotrophic Keratitis or Corneal Ulcer [clinicaltrials:NCT01794312]Safety and Efficacy Assessment of Monoprost® in Comparison With Lumigan® 0.01 % and Lumigan® 0.03% Unit Dose [clinicaltrials:NCT02017327]Efficacy and Safety of T2762 and Vismed® in Dry Eye Syndrome [clinicaltrials:NCT02023268]clinicaltrials:NCT02101359Efficacy and Safety Assessment of T2347 Versus Xalacom® in Ocular Hypertensive or Glaucomatous Patients [clinicaltrials:NCT02278614]
source [clinicaltrials_vocabulary:source]
Laboratoires Thea [clinicaltrials_resource:946184c4eeb3a96f61a79225badf46d8]
Bio2RDF identifier
946184c4eeb3a96f61a79225badf46d8
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:946184c4eeb3a96f61a79225badf46d8
organization [clinicaltrials_vocabulary:organization]
identifier
clinicaltrials_resource:946184c4eeb3a96f61a79225badf46d8
title
Laboratoires Thea
@en
type
label
Laboratoires Thea [clinicaltrials_resource:946184c4eeb3a96f61a79225badf46d8]
@en